Dendritic Cells

Measuring Immunity: Basic Biology and Clinical Assessment

Volumn , Issue , 2005, Pages 290-298

  Field, Kenneth ^a   Vuckovic, Slavica ^b   Hart, Derek N J ^b  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b MATER MEDICAL RESEARCH INSTITUTE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 66049153655     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-012455900-4/50286-5     Document Type: Chapter

References (87)

1. Almand B., Resser J.R., Lindman B., et al. Clinical significance of defective dendritic cell differentiation in cancer. Clin Cancer Res 2000, 6:1755-1766.
2. Arpinati M., Green C.L., Heimfeld S., Heuser J.E., Anasetti C. Granulocyte-colony stimulating factor mobilizes T helper 2-inducing dendritic cells. Blood 2000, 95:2484-2490.
3. Auffermann-Gretzinger S., Keeffe E.B., Levy S. Impaired dendritic cell maturation in patients with chronic, but not resolved, hepatitis C virus infection. Blood 2001, 97:3171-3176.
4. Bain C., Fatmi A., Zoulim F., Zarski J.-P., Trepo C., Inchauspe G. Impaired allostimulatory function of dendritic cells in chronic hepatitis C infection. Gastroenterology 2001, 120:512-524.
5. Banchereau J., Steinman R.M. Dendritic cells and the control of immunity. Nature 1998, 392:245-252.
6. Beckebaum S., Cicinnati V.R., Dworacki G., et al. Reduction in the circulating pDC1/pDC2 ratio and impaired function of ex vivo-generated DC1 in chronic hepatitis B infection. Clin Immunol 2002, 104:138-150.
7. Belardelli F., Ferrantini M. Cytokines as a link between innate and adaptive antitumor immunity. Trends Immunol 2002, 23:201-208.
8. Bell D., Chomarat P., Broyles D., et al. In breast carcinoma tissue, immature dendritic cells reside within the tumor, whereas mature dendritic cells are located in peritumoral areas. J Exp Med 1999, 190:1417-1426.
9. Blanco P., Palucka A.K., Gill M., Pascual V., Banchereau J. Induction of dendritic cell differentiation by IFN-alpha in systemic lupus erythematosus. Science 2001, 294:1540-1543.
10. Blomberg S., Eloranta M.L., Magnusson M., Alm G.V., Ronnblom L. Expression of the markers BDCA-2 and BDCA-4 and production of interferon-alpha by plasmacytoid dendritic cells in systemic lupus erythematosus. Arthritis Rheum 2003, 48:2524-2532.
11. Brown R.D., Pope B., Murray A., et al. Dendritic cells from patients with myeloma are numerically normal but functionally defective as they fail to up-regulate CD80 (B7-1) expression after huCD40LT stimulation because of inhibition by transforming growth factor-beta1 and interleukin-10. Blood 2001, 98:2992-2998.
12. Cameron P.U., Forsum U., Teppler H., Granelli-Piperno A., Steinman R.M. During HIV-1 infection most blood dendritic cells are not productively infected and can induce allogeneic CD4+ T cells clonal expansion. Clin Exp Immunol 1992, 88:226-236.
13. Caron G., Delneste Y., Roelandts E., et al. Histamine polarizes human dendritic cells into Th2 cell-promoting effector dendritic cells. J Immunol 2001, 167:3682-3686.
14. Cederblad B., Blomberg S., Vallin H., Perers A., Alm G.V., Ronnblom L. Patients with systemic lupus erythematosus have reduced numbers of circulating natural interferon-alpha-producing cells. J Autoimmun 1998, 11:465-470.
15. Cella M., Facchetti F., Lanzavecchia A., Colonna M. Plasmacytoid dendritic cells activated by influenza virus and CD40L drive a potent TH1 polarization. Nat Immunol 2000, 1:305-310.
16. Cella M., Jarrossay D., Facchetti F., et al. Plasmacytoid monocytes migrate to inflamed lymph nodes and produce large amounts of type I interferon. Nat Med 1999, 5:919-923.
17. Chehimi J., Starr S.E., Kawashima H., et al. Dendritic cells and IFN-alpha-producing cells are two functionally distinct non-B, non-monocytic HLA-DR+ cell subsets in human peripheral blood. Immunology 1989, 68:488-490.
18. Chehimi J., Campbell D.E., Azzoni L., et al. Persistent decreases in blood plasmacytoid dendritic cell number and function despite effective highly active antiretroviral therapy and increased blood myeloid dendritic cells in HIV-infected individuals. J Immunol 2002, 168:4796-4801.
19. Coventry B.J., Lee P.L., Gibbs D., Hart D.N. Dendritic cell density and activation status in human breast cancer-CD1a, CMRF-44, CMRF-56 and CD-83 expression. Br J Cancer 2002, 86:546-551.
20. Dzionek A., Fuchs A., Schmidt P., et al. BDCA-2, BDCA-3, and BDCA-4: three markers for distinct subsets of dendritic cells in human peripheral blood. J Immunol 2000, 165:6037-6046.
21. Dzionek A., Sohma Y., Nagafune J., et al. BDCA-2, a novel plasmacytoid dendritic cell-specific type II C-type lectin, mediates antigen capture and is a potent inhibitor of inter-feron {alpha}/{beta} induction. J Exp Med 2001, 194:1823-1834.
22. Egner W., Hart D.N. The phenotype of freshly isolated and cultured human bone marrow allostimulatory cells: possible heterogeneity in bone marrow dendritic cell populations. Immunology 1995, 85:611-620.
23. Egner W., Andreesen R., Hart D.N. Allostimulatory cells in fresh human blood: heterogeneity in antigen-presenting cell populations. Transplantation 1993, 56:945-950.
24. Fagnoni F.F., Oliviero B., Zibera C., et al. Circulating CD33+ large mononuclear cells contain three distinct populations with phenotype of putative antigen-presenting cells including myeloid dendritic cells and CD14+ monocytes with their CD16+ subset. Cytometry 2001, 45:124-132.
25. Fearnley D.B., Whyte L.F., Carnoutsos S.A., Cook A.H., Hart D.N. Monitoring human blood dendritic cell numbers in normal individuals and in stem cell transplantation. Blood 1999, 93:728-736.
26. Friberg M., Jennings R., Alsarraj M., et al. Indoleamine 2,3-dioxygenase contributes to tumor cell evasion of T cell-mediated rejection. Int J Cancer 2002, 101:151-155.
27. Gabrilovich D.I., Corak J., Ciernik I.F.aiKavanaugh^D., Carbone D.P. Decreased antigen presentation by dendritic cells in patients with breast cancer. Clin Cancer Res 1997, 3:483-490.
28. Gabrilovich D.I., Chen H.L., Girgis K.R., et al. Production of vascular endothelial growth factor by human tumors inhibits the functional maturation of dendritic cells. Nat Med 1996, 2:1096-1103.
29. Grassi F., Hosmalin A., Mcllroy D., Calvez V., Debre P., Autran B. Depletion in blood CD11c-positive dendritic cells from HIV-infected patients. Aids 1999, 13:759-766.
30. Gratama J.W., Kraan J., Keeney M., Granger V., Barnett D. Reduction of variation in T-cell subset enumeration among 55 laboratories using single-platform, three or four-color flow cytometry based on CD45 and SSC-based gating of lymphocytes. Cytometry 2002, 50:92-101.
31. Gratama J.W., Kraan J., Keeney M., Sutherland D.R., Granger V., Barnett D. Validation of the single-platform ISHAGE method for CD34(+) hematopoietic stem and progenitor cell enumeration in an international multicenter study. Cytotherapy 2003, 5:55-65.
32. Grohmann U., Fallarino F., Puccetti P. Tolerance, DCs and tryptophan: much ado about IDO. Trends Immunol 2003, 24:242-248.
33. Hagendorens M.M., Ebo D.G., Schuerwegh A.J., et al. Differences in circulating dendritic cell subtypes in cord blood and peripheral blood of healthy and allergic children. Clin Exp Allergy 2003, 33:633-639.
34. Hart D.N. Dendritic cells: unique leukocyte populations which control the primary immune response. Blood 1997, 90:3245-3287.
35. Hart D.N. Dendritic cells and their emerging clinical applications. Pathology 2001, 33:479-492.
36. Ho C.S., Munster D., Pyke C.M., Hart D.N., Lopez J.A. Spontaneous generation and survival of blood dendritic cells in mononuclear cell culture without exogenous cytokines. Blood 2002, 99:2897-2904.
37. Ho C.S., Lopez J.A., Vuckovic S., Pyke C.M., Hockey R.L., Hart D.N. Surgical and physical stress increases circulating blood dendritic cell counts independently of monocyte counts. Blood 2001, 98:140-145.
38. Hock B.D., Starling G.C., Daniel P.B., Hart D.N. Characterization of CMRF-44, a novel monoclonal antibody to an activation antigen expressed by the allostimulatory cells within peripheral blood, including dendritic cells. Immunology 1994, 83:573-581.
39. Hock B.D., Haring L.F., Ebbett A.M., Patton W.N., McKenzie J.L. Differential effects of G-CSF mobilisation on dendritic cell subsets in normal allogeneic donors and patients undergoing autologous transplantation. Bone Marrow Transplant 2002, 30:733-740.
40. Hock B.D., Fearnley D.B., Boyce A., et al. Human dendritic cells express a 95 kDa activation/differentiation antigen defined by CMRF-56. Tissue Antigens 1999, 53:320-334.
41. Hulstaert F., Hannet I., Deneys V., et al. Age-related changes in human blood lymphocyte subpopulations. II. Varying kinetics of percentage and absolute count measurements. Clin Immunol Immunopathol 1994, 70:152-158.
42. Hwu P., Du M.X., Lapointe R., Do M., Taylor M.W., Young H.A. Indoleamine 2,3-dioxygenase production by human dendritic cells results in the inhibition of T cell proliferation. J Immunol 2000, 164:3596-3599.
43. Kadowaki N., Ho S., Antonenko S., et al. Subsets of human dendritic cell precursors express different toll-like receptors and respond to different microbial antigens. J Exp Med 2001, 194:863-869.
44. Kanto T., Hayashi N., Takehara T., et al. Impaired allostimulatory capacity of peripheral blood dendritic cells recovered from hepatitis C virus-infected individuals. J Immunol 1999, 162:5584-5591.
45. Kunitani H., Shimizu Y., Murata H., Higuchi K., Watanabe A. Phenotypic analysis of circulating and intrahepatic dendritic cell subsets in patients with chronic liver diseases. J Hepatol 2002, 36:734-741.
46. Langenkamp A., Messi M., Lanzavecchia A., Sallusto F. Kinetics of dendritic cell activation: impact on priming of TH1, TH2 and nonpolarized T cells. Nat Immunol 2000, 1:311-316.
47. Lissoni P., Vigore L., Ferranti R., et al. Circulating dendritic cells in early and advanced cancer patients: diminished percent in the metastatic disease. J Biol Regul Homeost Agents 1999, 13:216-219.
48. Lopez J.A., Bioley G., Turtle C.J., et al. Single step enrichment of blood dendritic cells by positive immunoselection. J Immunol Methods 2003, 274:47-61.
49. Lu L., Thomson A.W. Dendritic cell tolerogenicity and prospects for dendritic cell-based therapy of allograft rejection and autimmune disease. Dendritic cells 2001, 587-607. Academic Press, London. 2nd edn. M. Lotze, A. Thomson (Eds.).
50. MacDonald K.P., Munster D.J., Clark G.J., Dzionek A., Schmitz J., Hart D.N. Characterization of human blood dendritic cell subsets. Blood 2002, 100:4512-4520.
51. Macey M.G., McCarthy D.A., Vogiatzi D., Brown K.A., Newland A.C. Rapid flow cytometric identification of putative CD14- and CD64- dendritic cells in whole blood. Cytometry 1998, 31:199-207.
52. Marroquin C.E., Westwood J.A., Lapointe R., et al. Mobilization of dendritic cell precursors in patients with cancer by flt3 ligand allows the generation of higher yields of cultured dendritic cells. J Immunother 2002, 25:278-288.
53. Matsuda H., Suda T., Hashizume H., et al. Alteration of balance between myeloid dendritic cells and plasmacytoid dendritic cells in peripheral blood of patients with asthma. Am J Respir Crit Care Med 2002, 166:1050-1054.
54. Matsue H., Takashima A. Apoptosis in dendritic cell biology. J Dermatol Sci 1999, 20:159-171.
55. Matsue H., Edelbaum D., Hartmann A.C., et al. Dendritic cells undergo rapid apoptosis in vitro during antigen-specific interaction with CD4+ T cells. J Immunol 1999, 162:5287-5298.
56. Mohty M., Jarrossay D., Lafage-Pochitaloff M., et al. Circulating blood dendritic cells from myeloid leukemia patients display quantitative and cytogenetic abnormalities as well as functional impairment. Blood 2001, 98:3750-3756.
57. Munn D.H., Sharma M.D., Lee J.R., et al. Potential regulatory function of human dendritic cells expressing indoleamine 2,3-dioxygenase. Science 2002, 297:1867-1870.
58. Olweus J., BitMansour A., Warnke R., et al. Dendritic cell ontogeny: a human dendritic cell lineage of myeloid origin. Proc Natl Acad Sci USA 1997, 94:12551-12556.
59. Osugi Y., Vuckovic S., Hart D.N.J. Myeloid blood CD11c+ dendritic cells and monocyte-derived dendritic cells differ in their ability to stimulate T lymphocytes. Blood 2002, 100:2858-2866.
60. Palucka A.K., Banchereau J., Blanco P., Pascual V. The interplay of dendritic cell subsets in systemic lupus ery-thematosus. Immunol Cell Biol 2002, 80:484-488.
61. Pockaj B.A., Basu G.D., Pathangey L.B., et al. Reduced T-cell and dendritic cell function is related to cyclooxygenase-2 overexpression and prostaglandin E2 secretion in patients with breast cancer. Ann Surg Oncol 2004, 11:328-339.
62. Pulendran B., Banchereau J., Burkeholder S., et al. Flt3-ligand and granulocyte colony-stimulating factor mobilize distinct human dendritic cell subsets in vivo. J Immunol 2000, 165:566-572.
63. Ratta M., Fagnoni F., Curti A., et al. Dendritic cells are functionally defective in multiple myeloma: the role of inter-leukin-6. Blood 2002, 100:230-237.
64. Reider N., Reider D., Ebner S., et al. Dendritic cells contribute to the development of atopy by an insufficiency in IL-12 production. J Allergy Clin Immunol 2002, 109:89-95.
65. Reis e Sousa C. Toll-like receptors and dendritic cells: for whom the bug tolls. Semin Immunol 2004, 16:27-34.
66. Rissoan M.-C., Soumelis V., Kadowaki N., et al. Reciprocal control of T helper cell and dendritic cell differentiation. Science 1999, 283:1183-1186.
67. Robinson S.P., Patterson S., English N., Davies D., Knight S.C., Reid C.D. Human peripheral blood contains two distinct lineages of dendritic cells. Eur J Immunol 1999, 29:2769-2778.
68. Scheinecker C., Zwolfer B., Koller M., Manner G., Smolen J.S. Alterations of dendritic cells in systemic lupus erythematosus: phenotypic and functional deficiencies. Arthritis Rheum 2001, 44:856-865.
69. Schnizlein-Bick C.T., Mandy F.F., O'Gorman M.R., et al. Use of CD45 gating in three and four-color flow cytometric immunophenotyping: guideline from the National Institute of Allergy and Infectious Diseases, Division of AIDS. Cytometry 2002, 50:46-52.
70. Shodell M., Siegal F.P. Circulating, interferon-producing plasmacytoid dendritic cells decline during human ageing. Scand J Immunol 2002, 56:518-521.
71. Siegal F.P., Kadowaki N., Shodell M., et al. The nature of the principal type 1 interferon-producing cells in human blood. Science 1999, 284:1835-1837.
72. Stent G., Reece J.C., Baylis D.C., et al. Heterogeneity of freshly isolated human tonsil dendritic cells demonstrated by intracellular markers, phagocytosis, and membrane dye transfer. Cytometry 2002, 48:167-176.
73. Szabolcs P., Park K.D., Reese M., Marti L., Broadwater G., Kurtzberg J. Absolute values of dendritic cell subsets in bone marrow, cord blood, and peripheral blood enumerated by a novel method. Stem Cells 2003, 21:296-303.
74. Tanaka H., Demeure C.E., Rubio M., Delespesse G., Sarfati M. Human monocyte-derived dendritic cells induce naive T cell differentiation into T helper cell type 2 (Th2) or Th1/Th2 effectors. Role of stimulator/responder ratio. J Exp Med 2000, 192:405-412.
75. Teig N., Moses D., Gieseler S., Schauer U. Age-related changes in human blood dendritic cell subpopulations. Scand J Immunol 2002, 55:453-457.
76. Troy A.J., Davidson P.J., Atkinson C.H., Hart D.N. CD1a dendritic cells predominate in transitional cell carcinoma of bladder and kidney but are minimally activated. J Urol 1999, 161:1962-1967.
77. Troy A.J., Summers K.L., Davidson P.J., Atkinson C.H., Hart D.N. Minimal recruitment and activation of dendritic cells within renal cell carcinoma. Clin Cancer Res 1998, 4:585-593.
78. Uchida Y., Kurasawa K., Nakajima H. Increase of dendritic cells of type 2 (DC2) by altered response to IL-4 in atopic patients. J Allergy Clin Immunol 2001, 108:1005-1011.
79. Upham J.W., Lundahl J., Liang H., Denburg J.A., O'Byrne P.M., Snider D.P. Simplified quantitation of myeloid dendritic cells in peripheral blood using flow cytometry. Cytometry 2000, 40:50-59.
80. Vakkila J., Thomson A.W., Vettenranta K., Sariola H., Saarinen-Pihkala U.M. Dendritic cell subsets in childhood and in children with cancer: relation to age and disease prognosis. Clin Exp Immunol 2004, 135:455-461.
81. von Bubnoff D., Koch S., Bieber T. New jobs for an old enzyme: the revival of IDO. Trends Immunol 2003, 24:296-297. author reply 8.
82. Vuckovic S., Florin T.H., Khalil D., et al. CD40 and CD86 upregulation with divergent CMRF44 expression on blood dendritic cells in inflammatory bowel diseases. Am J Gastroenterol 2001, 96:2946-2956.
83. Vuckovic S., Gardiner D., Field K., et al. Monitoring dendritic cells in clinical practice using a new whole blood single-platform TruCOUNT assay. J Immunol Methods 2004, 284:73-87.
84. Vuckovic S., Kim M., Khalil D., et al. Granulocyte-colony stimulating factor increases CD123hi blood dendritic cells with altered CD62L and CCR7 expression. Blood 2003, 101:2314-2317.
85. Vuckovic S., Hart D.N.J. Dendritic cells versus macrophages as antigen presenting cells: common and unique features. The Macrophage as Therapeutic Target 2002, 337-352. Springer, Oxford.
86. Zhang Y., Yoneyama H., Wang Y., et al. Mobilization of dendritic cell precursors into the circulation by administration of MIP-1alpha in mice. J Natl Cancer Inst 2004, 96:201-209.
87. Zinkernagel R.M. On cross-priming of MHC class I-specific CTL: rule or exception?. Eur J Immunol 2002, 32:2385-2392.